Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment
Go back to Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment| (NASDAQ: EDSA) | Delayed: 5.35 +0.10 (1.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.25 | 52 Week High | $ | |||
| Open | $5.35 | 52 Week Low | $ | |||
| Day High | $5.52 | P/E | N/A | |||
| Day Low | $5.12 | EPS | $ | |||
| Volume | 89,263 | |||||
